Cargando…
Progestin vs. Gonadotropin-Releasing Hormone Antagonist for the Prevention of Premature Luteinizing Hormone Surges in Poor Responders Undergoing in vitro Fertilization Treatment: A Randomized Controlled Trial
Objective: Progestin was recently used as an alternative of gonadotropin-releasing hormone (GnRH) analog for preventing premature luteinizing hormone (LH) surge with the aid of vitrification techniques, however, limited data were available about the potential of progestin in poor responders undergoi...
Autores principales: | Chen, Qiuju, Chai, Weiran, Wang, Yun, Cai, Renfei, Zhang, Shaozhen, Lu, Xuefeng, Zeng, Xiaojing, Sun, Lihua, Kuang, Yanping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6882854/ https://www.ncbi.nlm.nih.gov/pubmed/31824419 http://dx.doi.org/10.3389/fendo.2019.00796 |
Ejemplares similares
-
Gonadotropin-releasing hormone antagonist versus progestin for the prevention of premature luteinising hormone surges in poor responders undergoing in vitro fertilisation treatment: study protocol for a randomised controlled trial
por: Wang, Yun, et al.
Publicado: (2018) -
Diminished Ovarian Reserve Predisposes to Premature Luteinizing Hormone Surges in Gonadotropin-Releasing Hormone Antagonist Cycles in In vitro Fertilization
por: Kochhar, Puneet Kaur, et al.
Publicado: (2020) -
Elevated basal luteinizing hormone does not impair the outcome of human menopausal gonadotropin and medroxyprogesterone acetate treatment cycles
por: Sun, Lihua, et al.
Publicado: (2018) -
Medroxyprogesterone Acetate versus Gonadotropin-Releasing Hormone
Antagonist for the Prevention of Premature Luteinizing Hormone Surge in
hyper-responder women undergoing controlled ovarian stimulation for IVF/ICSI
Cycles
por: Tandulwadkar, Sunita, et al.
Publicado: (2023) -
Ganirelix and the prevention of premature luteinizing hormone surges
por: Mannaerts, Bernadette
Publicado: (2023)